Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MOG-IgG in neuromyelitis optica.
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.
[Spinal segmental myoclonus in multiple sclerosis (case report).]
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Yes.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality.
Disruption of structural and functional networks in long-standing multiple sclerosis.
Drug expenditure of high-cost patients and their characteristics in Finland.
Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis.
Bilateral hypogeusia caused by a small lesion in the lower midbrain tegmentum.
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.
Levels of plasma sulfatides C18:0 and C24:1 correlate with disease status in Relapsing-Remitting Multiple Sclerosis.
Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.
[Vitamin D and neurology.]
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
Automated patient-specific optimization of three-dimensional double-inversion recovery magnetic resonance imaging.
Vibsanin B Preferentially Targets HSP90β, Inhibits Interstitial Leukocyte Migration, and Ameliorates Experimental Autoimmune Encephalomyelitis.
Early CNS neurodegeneration in radiologically isolated syndrome.
Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis.
The relationship between cognitive function and high-resolution diffusion tensor MRI of the cingulum bundle in multiple sclerosis.
Brain MRI findings in Japanese patients with clinically isolated syndrome.
S1P and the birth of platelets.
Dietary interventions for multiple sclerosis.
A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance.
Pages
« first
‹ previous
…
372
373
374
375
376
377
378
379
380
…
next ›
last »